BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Methotrexate|DRUG: Capecitabine
Sponsor: University of Illinois at Chicago